Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma-Reference-Cited by-同舟云学术

Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma

Published:2009-04 Issue:2 Volume:35 Page:208-213
ISSN:0305-1846
Container-title:Neuropathology and Applied Neurobiology
language:en
Short-container-title:

Author:

Idbaih A.,Aimard J.,Boisselier B.,Marie Y.,Paris S.,Crinière E.,Carvalho Silva R.,Laigle-Donadey F.,Rousseau A.,Mokhtari K.,Thillet J.,Sanson M.,Hoang-Xuan K.,Delattre J.-Y.

Publisher

Wiley

Subject

Physiology (medical),Neurology (clinical),Neurology,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2990.2008.00977.x/fullpdf

Reference25 articles.

1. The 2007 WHO classification of tumours of the central nervous system;Louis;Acta Neuropathol,2007

2. Glioblastoma multiforme: the terminator;Holland;Proc Natl Acad Sci USA,2000

3. Issues of diagnostic review in brain tumor studies: from the brain tumor epidemiology consortium;Davis;Cancer Epidemiol Biomarkers Prev,2008

4. French brain tumor data bank: methodology and first results on 10 000 cases;Bauchet;J Neurooncol,2007

5. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma;International Journal of Molecular Sciences;2023-07-05

2. Glioblastoma Multiforme Tumors in Women Have a Lower Expression of Fatty Acid Elongases ELOVL2, ELOVL5, ELOVL6, and ELOVL7 than in Men;Brain Sciences;2022-10-06

3. Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer;Frontiers in Pharmacology;2021-11-15

4. Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation;Journal of Neuro-Oncology;2021-09

5. Exploring Predictors of Response to Dacomitinib in EGFR-Amplified Recurrent Glioblastoma;JCO Precision Oncology;2020-11